Integrating Metabolomics and Gut Microbiota to Identify Key Biomarkers and Regulatory Pathways Underlying Metabolic Heterogeneity in Childhood Obesity
Nutrients · 30.05.2025 · 17 (11) · 1876
DOI: 10.3390/nu17111876 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.05.2025. Verfasst von Zhiwei Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Public Nutrition and Health, National Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention, Bei…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pediatric Obesity, Metabolomics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Public Health Emergency Project Nutrition Health and Healthy Diet Campaign, Public Health Emergency Project Nutrition Health and Healthy Diet Campaign.
Abstract (Originalsprache)
Background/Objectives: Individuals with childhood obesity exhibit significant metabolic heterogeneity, necessitating precise biomarkers for risk stratification and assessment. This multi-omics investigation characterizes metabolic and microbial signatures underlying divergent metabolic phenotypes in the context of pediatric obesity.
Methods
We analyzed 285 Chinese children (5–7 years) stratified into five groups: wasting (WAS, n = 55), metabolically healthy/unhealthy and normal weight (MHWH, n = 54; MUWH, n = 67), and metabolically healthy/unhealthy obesity (MHO, n = 36; MUO, n = 73). Untargeted metabolomics (Orbitrap ID-X Tribrid™) and 16S rRNA sequencing were integrated with multivariate analyses (OPLS-DA with VIP > 1, FDR < 0.05; Maaslin 2 with TSS normalization and BH correction, FDR < 0.10).
Results
Analysis identified 225 differential metabolites and 12 bacterial genera. The proportion of steroids and their derivatives among differential metabolites in the MUO/MHO group was significantly lower than that in the OVOB/NOR and OVOB/WAS groups (2.12% vs. 7.9–14.1%). MUO displayed elevated C17 sphinganine and LysoPC (O-18:0) levels but reduced PI (16:0/14:1) levels. In contrast, OVOB showed upregulated glycerol phospholipids (LPCs and PSs) and downregulated PE species (e.g., PE(16:0/16:0)) as well as gut microbiota dysbiosis characterized by a higher Firmicutes/Bacteroidetes (F/B) ratio (2.07 vs. 1.24 in controls, p = 0.009) and reduced α diversity (Ace index, Chao1 index, and Shannon index values were lower in the OVOB group, Shannon index: 2.96 vs. 3.45, p = 0.03). SCFA-producing genera were negatively correlated with the OVOB group, while positively associated with PE(16:0/16:0). Internal validation showed differential metabolites had potential predictive efficacy for MUO/MHO (AUC = 0.967) and OVOB/NOR (AUC = 0.888).
Conclusions
We identified distinct lipid disruptions characterizing obesity subtypes, including steroid/terpene deficits and sphingolipid/ether lipid dysregulation in the MUO/MHO groups as well as phospholipid imbalance (↑LPC/PS↓PE) in the OVOB/NOR groups. The gut microbiota exhibited a profile characterized by low diversity, an increased F/B ratio, and a reduced abundance of SCFA-producing genera. These findings suggest potential biomarkers for childhood obesity stratification, though further validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Public Nutrition and Health, National Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
- Department of School Health, Beijing Center for Disease Control and Prevention, Beijing 100013, China.
- Key Laboratory of Diagnostic and Traceability Technologies for Food Poisoning, Beijing Center for Disease Control and Prevention, Beijing 100013, China.
ORCID-Profile: Zhiwei Xia, Shi Shen, Yi Yang, Junsheng Huo
Förderung
- the Public Health Emergency Project Nutrition Health and Healthy Diet Campaign
- Public Health Emergency Project Nutrition Health and Healthy Diet Campaign
Zitieren
APA
Xia, Z., Li, Y., Yin, J., Gong, Z., Sun, J., Shen, S., Yang, Y., Liu, T., Wang, L., & Huo, J. (2025). Integrating Metabolomics and Gut Microbiota to Identify Key Biomarkers and Regulatory Pathways Underlying Metabolic Heterogeneity in Childhood Obesity. Nutrients, 17(11), 1876. https://doi.org/10.3390/nu17111876
Vancouver
Xia Z, Li Y, Yin J, Gong Z, Sun J, Shen S, et al. Integrating Metabolomics and Gut Microbiota to Identify Key Biomarkers and Regulatory Pathways Underlying Metabolic Heterogeneity in Childhood Obesity. Nutrients. 2025;17(11):1876. doi:10.3390/nu17111876
BibTeX
@article{Xia2025,
author = {Xia, Zhiwei and Li, Yan and Yin, Jiyong and Gong, Zhaolong and Sun, Jing and Shen, Shi and Yang, Yi and Liu, Tingting and Wang, Liyuan and Huo, Junsheng},
title = {Integrating Metabolomics and Gut Microbiota to Identify Key Biomarkers and Regulatory Pathways Underlying Metabolic Heterogeneity in Childhood Obesity},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {11},
pages = {1876},
doi = {10.3390/nu17111876}
}
EUVIMED